AS Latvijas Juras medicinas centrs (RSE:LJM1R)
6.05
0.00 (0.00%)
At close: Feb 24, 2025
RSE:LJM1R Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Cash & Equivalents | 0.86 | 0.67 | 1.32 | 1.02 | 1.77 | Upgrade
|
Cash & Short-Term Investments | 0.86 | 0.67 | 1.32 | 1.02 | 1.77 | Upgrade
|
Cash Growth | 28.03% | -48.93% | 29.90% | -42.37% | -11.19% | Upgrade
|
Accounts Receivable | 0.08 | 0.4 | 0.43 | 0.1 | 0.06 | Upgrade
|
Other Receivables | 0.38 | 0.02 | 0.02 | 0.46 | 0.24 | Upgrade
|
Receivables | 0.46 | 0.42 | 0.46 | 0.56 | 0.3 | Upgrade
|
Inventory | 0.13 | 0.16 | 0.14 | 0.16 | 0.14 | Upgrade
|
Prepaid Expenses | 0 | - | - | 0.01 | 0.02 | Upgrade
|
Other Current Assets | - | 0.01 | 0.57 | 0.57 | - | Upgrade
|
Total Current Assets | 1.46 | 1.27 | 2.49 | 2.31 | 2.22 | Upgrade
|
Property, Plant & Equipment | 7.59 | 7.79 | 6.35 | 5.94 | 5.12 | Upgrade
|
Total Assets | 9.06 | 9.05 | 8.85 | 8.26 | 7.34 | Upgrade
|
Accounts Payable | 0.66 | 0.62 | 0.45 | 0.3 | 0.41 | Upgrade
|
Accrued Expenses | 0.31 | 1.04 | 0.84 | 0.81 | 0.63 | Upgrade
|
Current Income Taxes Payable | - | 0 | 0 | 0 | 0 | Upgrade
|
Current Unearned Revenue | 0.65 | 0.06 | 0.06 | 0.06 | 0.06 | Upgrade
|
Other Current Liabilities | 0.32 | 0.14 | 0.13 | 0.11 | 0.06 | Upgrade
|
Total Current Liabilities | 1.94 | 1.86 | 1.47 | 1.29 | 1.16 | Upgrade
|
Long-Term Unearned Revenue | 0.64 | 0.51 | 0.57 | 0.63 | 0.67 | Upgrade
|
Other Long-Term Liabilities | 0.1 | 0.48 | - | - | - | Upgrade
|
Total Liabilities | 2.68 | 2.85 | 2.04 | 1.92 | 1.83 | Upgrade
|
Common Stock | 1.12 | 1.12 | 1.12 | 1.12 | 1.12 | Upgrade
|
Retained Earnings | 2.69 | 2.51 | 3.21 | 2.75 | 1.92 | Upgrade
|
Comprehensive Income & Other | 2.57 | 2.57 | 2.47 | 2.47 | 2.47 | Upgrade
|
Total Common Equity | 6.38 | 6.2 | 6.81 | 6.34 | 5.52 | Upgrade
|
Shareholders' Equity | 6.38 | 6.2 | 6.81 | 6.34 | 5.52 | Upgrade
|
Total Liabilities & Equity | 9.06 | 9.05 | 8.85 | 8.26 | 7.34 | Upgrade
|
Net Cash (Debt) | 0.86 | 0.67 | 1.32 | 1.02 | 1.77 | Upgrade
|
Net Cash Growth | 28.03% | -48.93% | 29.90% | -42.37% | -11.19% | Upgrade
|
Net Cash Per Share | 1.08 | 0.84 | 1.65 | 1.27 | 2.21 | Upgrade
|
Filing Date Shares Outstanding | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | Upgrade
|
Total Common Shares Outstanding | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | Upgrade
|
Working Capital | -0.48 | -0.6 | 1.02 | 1.03 | 1.07 | Upgrade
|
Book Value Per Share | 7.98 | 7.75 | 8.51 | 7.93 | 6.90 | Upgrade
|
Tangible Book Value | 6.38 | 6.2 | 6.81 | 6.34 | 5.52 | Upgrade
|
Tangible Book Value Per Share | 7.98 | 7.75 | 8.51 | 7.93 | 6.90 | Upgrade
|
Land | - | 5.68 | 5.46 | 5.46 | 4.86 | Upgrade
|
Machinery | - | 5.84 | 4.04 | 3.38 | 2.64 | Upgrade
|
Construction In Progress | - | - | 0.08 | 0.07 | 0.36 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.